Drug Shortage Report for ATROPINE SULFATE INJECTION USP

Last updated on 2019-02-16
Report ID 62377
Drug Identification Number 00328154
Brand name ATROPINE SULFATE INJECTION USP
Common or Proper name ATROPINE SULFATE INJECTION USP
Company Name PFIZER CANADA ULC
Active Ingredient(s) ATROPINE SULFATE
Strength(s) 0.1MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10 x 10mL LifeShield
ATC code A03BA
ATC description BELLADONNAAND DERIVATIVES, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-11-16
Estimated end date
Actual end date 2019-02-15
Shortage status Resolved
Updated date 2019-02-15
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com